Clinical Trial Update: Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of SGLT2 inhibitors in people with hypertension at risk for or with pre-heart failure; status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Pre-Heart Failure, Hypertension | Phase 4 | Status: RECRUITING